Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Growth Factors and Hepatic Progenitor Cells in Acute Liver Failure

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified February 2011 by National Taiwan University Hospital.
Recruitment status was:  Recruiting
Sponsor:
Information provided by:
National Taiwan University Hospital
ClinicalTrials.gov Identifier:
NCT01312220
First received: March 8, 2011
Last updated: NA
Last verified: February 2011
History: No changes posted
  Purpose
To study the correlation of serological growth factors and the hepatic progenitor cells involved in liver regeneration of liver failure.

Condition
the Focus of the Study is to Correlate the Growth Factors in Serum With the Progenitor Cells in Liver

Study Type: Observational
Study Design: Observational Model: Cohort
Official Title: Relationship of Serological Growth Factors and Hepatic Progenitor Cells in Acute Liver Failure

Further study details as provided by National Taiwan University Hospital:

Biospecimen Retention:   Samples With DNA
Serum Liver piece

Estimated Enrollment: 10
Study Start Date: February 2011
Estimated Study Completion Date: February 2013
  Eligibility

Ages Eligible for Study:   18 Years to 75 Years   (Adult, Senior)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
acute liver failure who received liver transplantation
Criteria

Inclusion Criteria:

Acute liver failure Received iver transplantation

Exclusion Criteria:

Pregnancy Sepsis Heart failure

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01312220

Locations
Taiwan
NTUH
Taipei, Taiwan, 100
Sponsors and Collaborators
National Taiwan University Hospital
Investigators
Principal Investigator: CM Ho, MD National Taiwan University Hospital
  More Information

Responsible Party: CM Ho, NTUH
ClinicalTrials.gov Identifier: NCT01312220     History of Changes
Other Study ID Numbers: 201101061RC 
Study First Received: March 8, 2011
Last Updated: March 8, 2011
Health Authority: Taiwan: Department of Health

Additional relevant MeSH terms:
Liver Failure
Liver Failure, Acute
Hepatic Insufficiency
Liver Diseases
Digestive System Diseases
Mitogens
Mitosis Modulators
Molecular Mechanisms of Pharmacological Action

ClinicalTrials.gov processed this record on December 05, 2016